サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1679362

体外診断の世界市場：市場規模・シェア・動向分析 (製品別、検査場所別、最終用途別、用途別、技術別、地域別)、セグメント別予測 (2025年～2030年)

In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Test Location, By End Use, By Application, By Technology, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 320 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
体外診断の世界市場：市場規模・シェア・動向分析 (製品別、検査場所別、最終用途別、用途別、技術別、地域別)、セグメント別予測 (2025年～2030年)
出版日: 2025年02月26日
発行: Grand View Research
ページ情報: 英文 320 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

体外診断市場の成長と動向：

世界の体外診断の市場規模は、2030年には1,501億3,000万米ドルに達すると予測され、2025年から2030年にかけてCAGR 5.62%で成長すると予測されています。

高齢者人口の増加、COVID-19のパンデミック、診断の技術進歩が普及を後押ししています。携帯性、正確性、費用対効果という点での技術進歩は、インパクトの大きいレンダリング促進要因のひとつと予測されます。技術の進歩は、COVID-19の体外 (IVD) 診断薬の発売によってさらに加速され、PCRのような技術のための装置や消耗品の採用を強化しました。同市場における競合各社は、メーカーとユーザーのビジネスの流れを一定に保つため、契約やパートナーシップ戦略を採用するようになってきています。

これらの契約はまた、政府の検査室に対する厳しい価格抑制戦略の結果であり、政府の設定における価格を引き下げています。例えば、2021年4月、Seegene, Inc.のイタリア子会社は、715万件のSARS-CoV-2診断テストだけでなく、抽出試薬の供給のための公共調達のために1億825万米ドルの入札を受けました。SARS-CoV-2診断検査は、SARS-CoV-2診断検査とSARS-CoV-2抽出試薬の供給が主な目的ですが、サプライチェーンの多者間取引と複雑さが増します。がんと心血管疾患（CVDs）の世界の有病率の高さは、早期診断を促進し、消費者の絶え間なく進化するニーズに応えるための診断技術革新を促進すると予想されます。プラズモニックPCRのような新技術は、予測期間中に商業的に市場に参入し、既存製品のビジネスに悪影響を及ぼすと予想されます。

体外診断市場：分析概要

  • 体外診断（IVD）市場は、分子診断、次世代シーケンシング（NGS）、PoC検査の進歩に牽引され、高度な技術革新を示します。
  • 体外診断（IVD）市場の流通チャネルは、製品が医療施設、検査室、エンドユーザーにどのように届くかに重要な役割を果たし、市場へのリーチと業務効率に影響を与えます。
  • 体外診断（IVD）製品の価格設定は、製品種類、複雑さ、用途によって大きく異なります。
  • 試薬は2024年に体外診断市場で65.54%の最大シェアを占め、革新的なバイオマーカーキットの開発を目指す大手市場プレイヤーの研究開発努力が大きな原動力となっています。
  • 北米が体外診断業界を支配し、2024年には47.43%のシェアを占めました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 体外診断市場：変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
    • 市場機会の分析
    • サプライチェーン分析
    • 流通チャネル
  • 体外診断市場：分析ツール
    • 業界分析：ポーターのファイブフォース分析
    • PESTEL分析
  • IVD・LDTの償還：概要
  • 価格分析

第4章 体外診断市場：製品別の推定・動向分析

  • セグメントダッシュボード
  • 体外診断市場：変動分析、製品別 (2024年・2030年)
  • 装置
  • 装置：市場収益の推計・予測（金額（10億米ドル）、数量（1000台）、2018～2030年）
  • 試薬
  • サービス

第5章 体外診断市場：技術別の推定・動向分析

  • セグメントダッシュボード
  • 体外診断市場：変動分析、技術別 (2024年・2030年)
  • 免疫測定
    • 装置
    • 試薬
    • サービス
  • 血液学
    • 装置
    • 試薬
    • サービス
  • 臨床化学
    • 装置
    • 試薬
    • サービス
  • 分子診断
    • 装置
    • 試薬
    • サービス
  • 凝固
    • 装置
    • 試薬
    • サービス
  • 微生物
    • 装置
    • 試薬
    • サービス
  • その他
    • 装置
    • 試薬
    • サービス

第6章 体外診断市場：用途別の推定・動向分析

  • セグメントダッシュボード
  • 体外診断市場：変動分析、用途別 (2024年・2030年)
  • 感染症
  • 糖尿病
  • 腫瘍学/がん
  • 心臓病学
  • 腎臓学
  • 自己免疫疾患
  • 薬物検査
  • その他

第7章 体外診断市場：検査場所別の推定・動向分析

  • セグメントダッシュボード
  • 体外診断市場：変動分析、検査場所別 (2024年・2030年)
  • PoC (ポイントオブケア)
  • 在宅医療
  • その他

第8章 体外診断市場：最終用途別の推定・動向分析

  • セグメントダッシュボード
  • 体外診断市場：変動分析、最終用途別 (2024年・2030年)
  • 病院
  • 研究室
  • 在宅医療
  • その他

第9章 体外診断市場：地域別の推定・動向分析

  • 体外診断の市場シェア：地域別（10億米ドル、2024年・2030年）
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • デンマーク
    • ノルウェー
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東およびアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • クウェート

第10章 競合情勢

  • 最近の動向と影響分析：主要市場参入企業別
  • 企業分類
  • 世界企業の市場シェア分析（2024年）
  • 企業ヒートマップ分析
  • 戦略マッピング
    • 拡大
    • 企業合併・買収 (M&A)
    • パートナーシップとコラボレーション
    • 新製品の発売
    • 研究開発
  • 企業プロファイル
    • Abbott
    • Bio-Rad Laboratories, Inc
    • Siemens Healthineers AG
    • BIOMERIEUX
    • BD
    • QIAGEN
    • Quidel Corporation
    • F. Hoffmann-La Roche Ltd.
    • Danaher
    • Quest Diagnostics Incorporated
    • Agilent Technologies, Inc.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global In Vitro Diagnostics Market, By Region, 2018 - 2030 (USD Billion), Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
  • Table 5 Global In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 6 Global In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion), Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
  • Table 7 Global In Vitro Diagnostics Market, By Application, 2018 - 2030 USD Billion
  • Table 8 Global In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 9 Global In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 10 North America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 11 North America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 12 North America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 13 North America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 14 North America In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 15 North America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 16 U.S. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 17 U.S. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 18 U.S. In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 19 U.S. In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 20 U.S. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 21 Canada In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 22 Canada In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 23 Canada In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 24 Canada In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 25 Canada In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 26 Mexico In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 27 Mexico In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 28 Mexico In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 29 Mexico In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 30 Mexico In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 31 Europe In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 32 Europe In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 33 Europe In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 34 Europe In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 35 Europe In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 36 Europe In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 37 U.K. In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 38 U.K. In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 39 U.K. In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 40 U.K. In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 41 U.K. In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 42 Germany In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 43 Germany In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 44 Germany In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 45 Germany America In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 46 Germany In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 47 France In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 48 France In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 49 France In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 50 France In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 51 France In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 52 Spain In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 53 Spain In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 54 Spain In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 55 Spain In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 56 Spain In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 57 Italy In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 58 Italy In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 59 Italy In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 60 Italy In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 61 Italy In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 62 Asia Pacific In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 63 Asia Pacific In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 64 Asia Pacific In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 65 Asia Pacific In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 66 Asia-Pacific In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 67 Asia-Pacific In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 68 China In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 69 China In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 70 China In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 71 China In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 72 China In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 73 Japan In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 74 Japan In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 75 Japan In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 76 Japan In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 77 Japan In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 78 India In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 79 India In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 80 India In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 81 India In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 82 India In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 83 South Korea In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 84 South Korea In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 85 South Korea In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 86 South Korea In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 87 South Korea In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 88 Australia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 89 Australia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 90 Australia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 91 Australia In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 92 Australia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 93 Latin America In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 94 Latin America In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 95 Latin America In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 96 Latin America In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 97 Latin America In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 98 Latin America In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 99 Brazil In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 100 Brazil In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 101 Brazil In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 102 Brazil In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 103 Brazil In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 104 Argentina In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 105 Argentina In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 106 Argentina In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 107 Argentina In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 108 Argentina In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 109 MEA In Vitro Diagnostics Market, By Country, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 110 MEA In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 111 MEA In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 112 MEA In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 113 MEA In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 114 MEA In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 115 South Africa In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 116 South Africa In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 117 South Africa In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 118 South Africa In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 119 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 120 UAE In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 121 UAE In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 122 UAE In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 123 UAE In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 124 UAE In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion) million
  • Table 125 Saudi Arabia In Vitro Diagnostics Market, By Product, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 126 Saudi Arabia In Vitro Diagnostics Market, By Technology, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 127 Saudi Arabia In Vitro Diagnostics Market, By Application, 2018 - 2030 (USD Billion)
  • Table 128 Saudi Arabia In Vitro Diagnostics Market, By End Use, 2018 - 2030 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
  • Table 129 Saudi Arabia In Vitro Diagnostics Market, By Test Location, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 In Vitro Diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 In vitro diagnostic market snapshot
  • Fig. 10 Parent market outlook, 2024
  • Fig. 11 In vitro diagnostic market driver impact
  • Fig. 12 Global elderly population
  • Fig. 13 New cancer cases by year
  • Fig. 14 In vitro diagnostic market restraint impact
  • Fig. 15 Market entry strategy
  • Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 IVD market: Product outlook and key takeaways
  • Fig. 19 IVD market: Products movement analysis
  • Fig. 20 Instruments market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 21 Reagents market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 22 Services market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 IVD market: Technology outlook and key takeaways
  • Fig. 24 IVD Market: Technology movement analysis
  • Fig. 25 Immunoassay market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 26 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 27 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 28 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Hematology market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 30 Instruments market for hematology estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 31 Reagents market for hematology estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 32 Services market for hematology estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 34 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 35 Reagents market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 36 Services market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 37 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 38 Instruments market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 39 Reagents market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 40 Services market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Coagulation market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 42 Instruments market for coagulation estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 43 Reagents market for coagulation estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 44 Services market for coagulation estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 Microbiology market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 46 Instruments market for microbiology estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 47 Reagents market for microbiology estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 48 Services market for microbiology estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 Others market estimates and forecast, 2018 - 2030 (USD Billion)billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million
  • Fig. 50 Instruments others market estimates and forecast, 2018 - 2030 (USD Billion), volume, number of instruments, in thousands
  • Fig. 51 Reagents others market estimates and forecast, 2018 - 2030 (USD Billion), volume, reagents, number of tests in million
  • Fig. 52 Services market for other technology estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 53 IVD market: Application outlook and key takeaways
  • Fig. 54 IVD market: Application movement analysis
  • Fig. 55 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 Diabetes market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 Oncology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 58 Cardiology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 59 Nephrology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 Drug testing market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 62 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 63 IVD market: End Use outlook and key takeaways
  • Fig. 64 IVD treatment market: End Use movement analysis
  • Fig. 65 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 66 Laboratory market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 67 Home care market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 68 Other market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 69 IVD market: test location outlook and key takeaways
  • Fig. 70 IVD treatment market: Test location movement analysis
  • Fig. 71 Point-of-care market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 72 Homecare market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 73 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 74 IVD Market: Regional outlook and key takeaways
  • Fig. 75 IVD market: Regional movement analysis
  • Fig. 76 North America
  • Fig. 77 North America. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 78 U.S. key country dynamics
  • Fig. 79 U.S. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 80 Canada key country dynamics
  • Fig. 81 Canada market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 82 Mexico key country dynamics
  • Fig. 83 Mexico market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 84 Europe
  • Fig. 85 Europe market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 86 U.K. key country dynamics
  • Fig. 87 U.K. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 88 Germany key country dynamics
  • Fig. 89 Germany market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 90 Spain key country dynamics
  • Fig. 91 Spain market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 92 France key country dynamics
  • Fig. 93 France market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 94 Italy key country dynamics
  • Fig. 95 Italy market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 96 Denmark key country dynamics
  • Fig. 97 Denmark market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 98 Sweden key country dynamics
  • Fig. 99 Sweden market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 100 Norway key country dynamics
  • Fig. 101 Norway market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 102 Asia Pacific
  • Fig. 103 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 104 Japan key country dynamics
  • Fig. 105 Japan market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 106 China key country dynamics
  • Fig. 107 China. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 108 India key country dynamics
  • Fig. 109 India. market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 110 South Korea key country dynamics
  • Fig. 111 South Korea market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 112 Thailand key country dynamics
  • Fig. 113 Thailand market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 114 Australia key country dynamics
  • Fig. 115 Australia market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 116 Latin America
  • Fig. 117 Latin America market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 118 Brazil key country dynamics
  • Fig. 119 Brazil market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 120 Argentina key country dynamics
  • Fig. 121 Argentina market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 122 MEA
  • Fig. 123 MEA market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 124 South Africa key country dynamics
  • Fig. 125 South Africa market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 126 UAE key country dynamics
  • Fig. 127 UAE market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 128 Saudi Arabia key country dynamics
  • Fig. 129 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Billion, volume, number of instruments, in thousands, volume, reagents, number of tests in million)
  • Fig. 130 Ansoff matrix
  • Fig. 131 Competition categorization
  • Fig. 132 Company market share analysis, 2024
  • Fig. 133 Global mass spectrometry company market share analysis, 2024
  • Fig. 134 North America mass spectrometry company market share analysis, 2024
  • Fig. 135 Europe mass spectrometry company market share analysis, 2024
  • Fig. 136 Asia Pacific mass spectrometry company market share analysis, 2024
  • Fig. 137 Global immunoassay company market share analysis, 2024
  • Fig. 138 North America immunoassay company market share analysis, 2024
  • Fig. 139 Europe immunoassay company market share analysis, 2024
  • Fig. 140 Asia Pacific immunoassay company market share analysis, 2024
  • Fig. 141 Global PCR company market share analysis, 2024
  • Fig. 142 North America PCR company market share analysis, 2024
  • Fig. 143 Europe PCR company market share analysis, 2024
  • Fig. 144 Asia Pacific PCR company market share analysis, 2024
  • Fig. 145 Company market position analysis
  • Fig. 146 Company market position analysis
  • Fig. 147 Company market position analysis
  • Fig. 148 Company profiles
  • Fig. 149 Regional network map
目次
Product Code: 978-1-68038-080-4

In Vitro Diagnostic Market Growth & Trends:

The global in vitro diagnostics market size is expected to reach USD 150.13 billion in 2030 and is projected to grow at a CAGR of 5.62% from 2025 to 2030. driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

In Vitro Diagnostics Market Report Highlights:

  • The IVD market demonstrates a high degree of innovation, driven by advancements in molecular diagnostics, next-generation sequencing (NGS), and point-of-care testing.
  • The distribution channels for in vitro diagnostics (IVD) market play a critical role in how products reach healthcare facilities, laboratories, and End Users, impacting market reach and operational efficiency
  • The pricing of In vitro diagnostics (IVD) products varies significantly based on product type, complexity, and application.
  • Reagents held the largest share of 65.54% of the in vitro diagnostics market in 2024, driven by significant R&D efforts from leading market players aiming to develop innovative biomarker kits
  • North America dominated the in vitro diagnostics industry and accounted for a 47.43% share in 2024

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. Test Location
    • 1.2.5. End Use
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
  • 1.7. Details of primary research
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis (Model 1)
      • 1.9.1.1. Approach 1: Commodity flow approach
    • 1.9.2. Volume price analysis (Model 2)
      • 1.9.2.1. Approach 2: Volume price analysis
  • 1.10. Research Scope and Assumptions
    • 1.10.1. List of Secondary Sources
    • 1.10.2. List of Primary Sources
    • 1.10.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. In Vitro Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Introduction of Technologically Advanced Products
      • 3.2.1.2. Increasing Demand for PoC Testing
      • 3.2.1.3. Growing Prevalence of Target Diseases
      • 3.2.1.4. Increasing External Funding for R&D
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Presence of Ambiguous Regulatory Framework
      • 3.2.2.2. High Capital Investment
      • 3.2.2.3. High Prices of Molecular Diagnostic Tests
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Supply Chain Analysis
    • 3.2.5. Distribution Channel
      • 3.2.5.1. Direct Sales
      • 3.2.5.2. Distributors Network
      • 3.2.5.3. E-commerce and Online Platforms
      • 3.2.5.4. Major Distributors
  • 3.3. In Vitro Diagnostics Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Legal landscape
  • 3.4. Reimbursement Overview of IVDs and LDTs
  • 3.5. Pricing Analysis

Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. In Vitro Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Billion)
  • 4.3. Instruments
  • 4.4. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)Reagents
    • 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. In Vitro Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Billion)
  • 5.3. Immunoassay
    • 5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.3.2. Instruments
      • 5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Units)
    • 5.3.3. Reagents
      • 5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.3.4. Services
      • 5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Hematology
    • 5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.4.2. Instruments
      • 5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.4.3. Reagents
      • 5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.4.4. Services
      • 5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Clinical Chemistry
    • 5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.5.2. Instruments
      • 5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.5.3. Reagents
      • 5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.5.4. Services
      • 5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Molecular Diagnostics
    • 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.6.2. Instruments
      • 5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.6.3. Reagents
      • 5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.6.4. Services
      • 5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Coagulation
    • 5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.7.2. Instruments
      • 5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.7.3. Reagents
      • 5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.7.4. Services
      • 5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. Microbiology
    • 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.8.2. Instruments
      • 5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.8.3. Reagents
      • 5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.8.4. Services
      • 5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 5.9.2. Instruments
      • 5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
    • 5.9.3. Reagents
      • 5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
    • 5.9.4. Services
      • 5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. In Vitro Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Billion)
  • 6.3. Infectious Disease
    • 6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Diabetes
    • 6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Oncology/Cancer
    • 6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Cardiology
    • 6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Nephrology
    • 6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. Autoimmune Diseases
    • 6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.9. Drug Testing
    • 6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.10. Others
    • 6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, 2024 & 2030 (USD Billion)
  • 7.3. Point of Care
    • 7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4. Home-care
    • 7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. In Vitro Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.4. Laboratory
    • 8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.5. Home Care
    • 8.5.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 8.6. Others
    • 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)

Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. In Vitro Diagnostics Market Share, By Region, 2024 & 2030, USD Billion
  • 9.2. North America
    • 9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key Country Dynamics
      • 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.2.3. Competitive Insights
      • 9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.3. Canada
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.3.3. Competitive Insights
      • 9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.2.4. Mexico
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.2.4.3. Competitive Insights
      • 9.2.4.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.3. Europe
    • 9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.2. U.K.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.2.3. Competitive Insights
      • 9.3.2.4. U.K. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.3.3. Competitive Insights
      • 9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.4. France
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.4.3. Competitive Insights
      • 9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.5. Italy
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.5.3. Competitive Insights
      • 9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.6. Spain
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.6.3. Competitive Insights
      • 9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.7. Sweden
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.7.3. Competitive Insights
      • 9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.8.3. Competitive Insights
      • 9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.3.9. Norway
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 9.3.9.3. Competitive Insights
      • 9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 9.4.2. China
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.2.3. Competitive Insights
      • 9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.3.3. Competitive Insights
      • 9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.4. India
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.4.3. Competitive Insights
      • 9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.5. South Korea
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.5.3. Competitive Insights
      • 9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.6. Australia
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.6.3. Competitive Insights
      • 9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.4.7. Thailand
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 9.4.7.3. Competitive Insights
      • 9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.5. Latin America
    • 9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.2.3. Competitive Insights
      • 9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.5.3. Argentina
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.5.3.3. Competitive Insights
      • 9.5.3.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.2. Saudi Arabia
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.2.3. Competitive Insights
      • 9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.3. UAE
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.3.3. Competitive Insights
      • 9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.4. South Africa
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.4.3. Competitive Insights
      • 9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
    • 9.6.5. Kuwait
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 9.6.5.3. Competitive Insights
      • 9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis by Key Market Participants
  • 10.2. Company Categorization
  • 10.3. Global Company Market Share Analysis, 2024
  • 10.4. Company Heat Map Analysis
  • 10.5. Strategy Mapping
    • 10.5.1. Expansion
    • 10.5.2. Mergers & Acquisition
    • 10.5.3. Partnerships & Collaborations
    • 10.5.4. New Product Launches
    • 10.5.5. Research And Development
  • 10.6. Company Profiles
    • 10.6.1. Abbott
      • 10.6.1.1. Participant's Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Recent Developments
    • 10.6.2. Bio-Rad Laboratories, Inc
      • 10.6.2.1. Participant's Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Recent Developments
    • 10.6.3. Siemens Healthineers AG
      • 10.6.3.1. Participant's Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Recent Developments
    • 10.6.4. BIOMERIEUX
      • 10.6.4.1. Participant's Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Recent Developments
    • 10.6.5. BD
      • 10.6.5.1. Participant's Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Recent Developments
    • 10.6.6. QIAGEN
      • 10.6.6.1. Participant's Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Recent Developments
    • 10.6.7. Quidel Corporation
      • 10.6.7.1. Participant's Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Recent Developments
    • 10.6.8. F. Hoffmann-La Roche Ltd.
      • 10.6.8.1. Participant's Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Recent Developments
    • 10.6.9. Danaher
      • 10.6.9.1. Participant's Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Recent Developments
    • 10.6.10. Quest Diagnostics Incorporated
      • 10.6.10.1. Participant's Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Recent Developments
    • 10.6.11. Agilent Technologies, Inc.
      • 10.6.11.1. Participant's Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Recent Developments